Trump administration resolves fentanyl dispute but congressional support needed for broader crackdown
(Reuters Health)

The Trump administration has resolved an internal dispute over how to handle new variants of fentanyl that it believes can beef up the fight against the deadly synthetic painkiller without hindering research to ease the opioid crisis, according to a draft agreement seen by Reuters.